Linked Life Data

7514638

Source:http://linkedlifedata.com/resource/pubmed/id/7514638

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
1994-6-21
pubmed:abstractText
Recent evidence suggests adhesion molecules play an important role in the function of leukocytes. Because human eosinophils are known to express beta 2 integrins, we hypothesized that these adhesion molecules mediate the effector function of eosinophils. Normal human eosinophils incubated in albumin-coated polystyrene plates released granule protein and produced superoxide anion when stimulated with human recombinant granulocyte-macrophage CSF (rGM-CSF), platelet-activating factor (PAF), or PMA. Simultaneous monitoring of eosinophil adhesion and degranulation showed that degranulation was always preceded by cellular adhesion regardless of stimuli. Furthermore, eosinophil degranulation induced by human rGM-CSF and PAF was abolished in suspension culture of the cells when the cell suspensions were gently stirred. To identify the molecules involved in this adhesion-dependent degranulation, we have investigated the effects of mAbs (mAb) against beta 2 integrins. mAb reactive with CD18 markedly inhibited the eosinophil adhesion and degranulation induced by PAF and human rGM-CSF. mAb reactive with CD11b also moderately inhibited the adhesion and degranulation. In contrast, mAb reactive with CD11a slightly enhanced or showed no effect on the adhesion and degranulation by human rGM-CSF or PAF. Superoxide production induced by human rGM-CSF and PAF was also abolished by the treatment of cells with anti-CD18 mAb. mAb against CD11b and CD18 had little effect on degranulation and superoxide production induced by PMA. These results indicate that CD11b/CD18 (Mac-1)-dependent cellular adhesion plays an important role in the degranulation and superoxide production of eosinophils induced by human rGM-CSF and PAF, and that these mechanisms may be employed in vivo where eosinophils contact with stromal cells and/or proteins.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
152
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5457-67
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed:year
1994
pubmed:articleTitle
CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet-activating factor.
pubmed:affiliation
Department of Immunology, Mayo Clinic, Rochester, MN 55905.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't